Clinical trial
Outcome of seCond Generation Drug-ELuting Stents in Patients With Diabetes Mellitus: cOmparison of Three differenT Drug Regimens
NCT01293773 is registered in ClinicalTrials.gov with Policlinico Casilino ASL RMB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Outcome of seCond Generation Drug-ELuting Stents in Patients With Diabetes Mellitus: cOmparison of Three differenT Drug Regimens
- Lead sponsor
- Policlinico Casilino ASL RMB
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- October 31, 2010
- Completion date
- December 31, 2012
- Enrollment
- 0 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.